Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin

References

• Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010;159:1102–7.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, et al. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation. Int J Cardiol. 2013;168:4678–84.
   PubMed Web of Science ®Google Scholar
• Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009;119:1363–9.
   PubMed Web of Science ®Google Scholar
• Olesen JB, Lip GY, Kamper AL, Hommel K, Kober L, Lane DA, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367:625–35.
   PubMed Web of Science ®Google Scholar
• Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, et al. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. J Amer Coll Cardiol. 2014;64:2471–82.
   PubMed Web of Science ®Google Scholar
• Hrafnkelsdottir T, Ottosson P, Gudnason T, Samuelsson O, Jern S. Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension. Hypertension. 2004;44:300–4.
   PubMed Web of Science ®Google Scholar
• Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Amer J Kidney Dis. 2004;43:244–53.
   PubMed Web of Science ®Google Scholar
• Keller C, Katz R, Cushman M, Fried LF, Shlipak M. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol. 2008;9:1471–2369.
   Web of Science ®Google Scholar
• Sjoland JA, Sidelmann JJ, Brabrand M, Pedersen RS, Pedersen JH, Esbensen K, et al. Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost. 2007;98:339–45.
   PubMed Web of Science ®Google Scholar
• Undas A, Kolarz M, Kopec G, Tracz W. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality. Nephrol Dial Transplant. 2008;23:2010–5.
   PubMed Web of Science ®Google Scholar
• Holloway DS, Vagher JP, Caprini JA, Simon NM, Mockros LF. Thrombelastography of blood from subjects with chronic renal failure. Thromb Res. 1987;45:817–25.
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Asinger RW, Herzog CA. Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Amer Soc Nephrol. 2011;6:2599–604.
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011;6:2662–8.
   PubMed Web of Science ®Google Scholar
• Marinigh R, Lane DA, Lip GY. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol. 2011;57:1339–48.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137:263–72.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Annals Int Med. 1999;130:461–70.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;130:461–70.
   Google Scholar
• Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:81–90.
   PubMedGoogle Scholar
• Ranjit P, Lau Y, Lip GY, Blann AD. Development and validation of a new assay for assessing clot integrity. Vascul Pharmacol. 2015;71:102–7.
   PubMed Web of Science ®Google Scholar
• Machin D, Campbell M. Statistical tables for the design of clinical trials. Oxford, UK: Blackwell, 1987.
   Google Scholar
• Chapman MP, Moore EE, Burneikis D, Moore HB, Gonzalez E, Anderson KC, et al. Thrombelastographic pattern recognition in renal disease and trauma. J Surg Res. 2015;194:1–7.
   PubMed Web of Science ®Google Scholar
• Zabczyk M, Blomback M, Majewski J, Karkowski G, Wallen HN, Undas A, et al. Assays of fibrin network properties altered by VKAs in atrial fibrillation – importance of using an appropriate coagulation trigger. Thromb Haemost. 2015;113:851–61.
   PubMed Web of Science ®Google Scholar
• Zabczyk M, Majewski J, Karkowski G, Malinowski KP, Undas A. Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3days of treatment: relation to coagulation factors and thrombin generation. Thromb Res. 2015;136:832–8.
   PubMed Web of Science ®Google Scholar
• Neeves KB, Illing DA, Diamond SL. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J. 2010;98:1344–52.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107:87–92.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62:997–1004.
   PubMed Web of Science ®Google Scholar